NASD · Healthcare · Drug Manufacturers - Specialty & Generic · Canada
Tilray Brands Inc is a small cap company (market value between $300 million and $2 billion) in the Drug Manufacturers - Specialty & Generic industry.
Tilray Brands is a consumer products company operating across cannabis, beverages, wellness, and distribution. The company cultivates and sells medical and adult-use cannabis products in Canada and internationally, produces craft beers and spirits, and offers hemp-based food products. Operations span North America, Europe, Australia, and Latin America.
From its FY2026 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Tilray Brands Inc stock.
No reliable verdict: intrinsic value $12.65 per share, market price $2.53 (as of 2026-10-30).
A revenue multiple, discounted for its losses, would put the shares at $12.65: 5 times the price of $2.53. A multiple has nothing to stand on when a company earns almost nothing on its sales and has no filings in our archive, so we do not publish a verdict on this one.
Leak Score: 69/100 on 9 of 12 signals (Faint Leak).
7 more funds hold it; the full list is part of the paid plan.
All 84 Drug Manufacturers - Specialty & Generic stocks
We do not publish a verdict on TLRY. A revenue multiple, discounted for its losses, would put the shares at $12.65: 5 times the price of $2.53. A multiple has nothing to stand on when a company earns almost nothing on its sales and has no filings in our archive, so we do not publish a verdict on this one.
We do not publish one (as of the 2026-10-30 close). A revenue multiple, discounted for its losses, would put the shares at $12.65: 5 times the price of $2.53. A multiple has nothing to stand on when a company earns almost nothing on its sales and has no filings in our archive, so we do not publish a verdict on this one.
69 out of 100, which we rate "Faint Leak", on 9 of 12 value investing signals.